| Nicole Demke, | |
|
515 S 700 E Ste 2a, Slc, UT 84102-2855 | |
| (800) 434-8923 | |
| Not Available |
| Full Name | Nicole Demke |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 515 S 700 E Ste 2a, Slc, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740894336 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 103TC0700X (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Demke, 515 S 700 E # Suited2a, Slc, UT 84102-2801 Ph: () - | Nicole Demke, 515 S 700 E Ste 2a, Slc, UT 84102-2855 Ph: (800) 434-8923 |
News Archive
Solvay Pharmaceuticals, Inc., has announced that it submitted a supplemental New Drug Application (sNDA) for AndroGel (testosterone gel) 1% CIII to the U.S. Food and Drug Administration (FDA) for treatment in male adolescents ages 13-17 years old with primary or secondary hypogonadism.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
A computer-based diabetes simulation tool developed by University of Virginia researchers is now commercially available, thanks to a partnership with the Charlottesville-based medical research firm The Epsilon Group. The simulator is the only protocol that has been accepted by the U.S. Food and Drug Administration as an alternative to animal testing of Type 1 diabetes control strategies.
It's been a burning question in melanoma research: Tumor cells are full of ultraviolet (UV)-induced genetic damage caused by sunlight exposure, but which mutations drive this cancer? None have been conclusively tied to melanoma. The sheer abundance of these passenger mutations has obscured the search for genetic driver mutations that actually matter in melanoma development and progression.
A group of small molecules called EETs - currently under scrutiny as possible treatment targets for a host of cardiovascular diseases - may also drive the growth and spread of cancer, according to researchers at the Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) and other institutions.
› Verified 1 days ago
Matthew Davis, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 501 S Chipeta Way, Slc, UT 84108 Phone: 801-583-2500 | |
Dr. Lara Leishman, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 231 E 400 S, Slc, UT 84111 Phone: 801-363-1189 Fax: 801-363-1198 | |
Dr. Melvin F. Nosanchuk, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1646 Kensington Ave, Slc, UT 84105 Phone: 801-467-4875 Fax: 801-467-4875 | |
Dr. Lindsay D Wilson-barlow, PH.D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1208 E 3300 S, Slc, UT 84106 Phone: 801-483-1600 | |
Wendy Dawn Hoyt, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 349 E 900 S, Slc, UT 84111 Phone: 801-532-3614 | |
Dr. Tanya Michelle Miller, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 500 Foothill Dr, Slc, UT 84148 Phone: 801-582-1565 Fax: 801-584-2544 | |
Dr. Larry Brad Peck, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 44 N Medical Dr, Slc, UT 84113 Phone: 801-584-8533 |